Quarterly report pursuant to Section 13 or 15(d)

Note 6 - Capital Stock

v3.10.0.1
Note 6 - Capital Stock
6 Months Ended
Jul. 01, 2018
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]
6.
Capital stock
 
Common shares
 
Issued and outstanding:
 
The issued and outstanding number of common shares included in shareholders’ equity consisted of the following:
 
   
Number

of shares
   
$
 
                 
Balance at December 31, 2017
   
16,992,627
     
396
 
Share issuance (1)
   
310,883
     
3
 
Balance at July 1, 2018
   
17,303,510
     
399
 
 
 
(
1
)
310,883
new common shares resulted from
211,135
exercised stock options and
99,748
vested RSUs during the period.
 
Stock Options
 
For more detailed information regarding the Company’s stock option arrangements, see Note
6
of the consolidated financial statements within the Company’s Form
10
-K for the fiscal period ended
December 31, 2017.
The Company granted
335,929
stock options during the
three
and
six
months period ended
July 1, 2018.
A summary of stock option activity for the
six
months period ended
July 1, 2018
is as follows:
 
   
Number

of options
   
Weighted
average
exercise
price
   
Aggregate
intrinsic
value
   
Weighted
average
remaining
contractual
term
(years)
 
Outstanding at December 31, 2017
   
1,870,753
    $
1.39
     
61
     
8.6
 
                                 
Options granted
   
335,929
    $
2.07
     
 
     
 
 
Exercised
   
(211,135
)    
1.71
     
 
     
 
 
Forfeited
   
(316,180
)   $
1.25
     
 
     
 
 
Outstanding at July 1, 2018
   
1,679,367
    $
1.52
    $
585
     
8.8
 
Exercisable at July 1, 2018
   
480,741
    $
1.60
    $
556
     
8.1
 
 
During the
three
month periods ended
July 1, 2018
and
July 2, 2017,
the Company recorded stock-based compensation expense related to stock options and a corresponding increase in additional paid-in capital of
$34
and
$11,
respectively. During the
six
month periods ended
July 1, 2018
and
July 2, 2017,
the Company recorded stock-based compensation expense related to stock options and a corresponding increase in additional paid-in capital of
$59
and
$23,
respectively.
 
Certain stock options outstanding have market conditions such that the awards are vested and exercisable only if the Company’s stock exceeds specified targets during the vesting period. If the market conditions are
not
met, the stock options will
not
vest and will expire.
 
 
Restricted Stock Units
 
 
For more detailed information regarding the Company’s Restricted Stock Units (“RSUs”) arrangements, see Note
6
of the consolidated financial statements within the Company’s Form
10
-K for the fiscal period ended
December 31, 2017.
There were
25,000
RSUs granted during the
six
months ended
July 1, 2018.
A summary of the RSUs activity for the
six
month period ended
July 1, 2018
is as follows: 
 
 
   
Outstanding
RSU
s
   
Weighted
average
stock
price
   
Weighted
average
remaining
contractual
term (years)
 
Outstanding balance at December 31, 2017
   
576,023
    $
1.13
     
1.84
 
RSUs granted
   
25,000
    $
2.37
     
 
 
RSUs vested and issued in shares
   
(99,748
)   $
1.40
     
 
 
RSUs forfeited
   
(67,689
)   $
0.97
     
 
 
Outstanding balance at July 1, 2018
   
433,586
    $
0.98
     
1.33
 
 
 
Certain RSUs outstanding have a market condition such that the awards are vested and issuable only if the market price of the Company’s stock meets or exceeds a specified target during the vesting period. If the market condition is
not
met, the RSUs will
not
vest and will be forfeited.
 
Stock based compensation expense (recovery) recognized during the
three
month periods ended
July 1, 2018
and
July 2, 2017
related to the RSUs was
$43
and (
$18
), respectively. The recovery of stock based compensation was due to the reversal of unvested RSUs for terminated employees. Stock based compensation recognized during the
six
month periods ended
July 1, 2018
and
July 2, 2017
related to the RSUs was
$144
and
$173,
respectively.